Dantrolene Sodium
NDC 64850-841, dantrolene sodium, capsule, from Elite Laboratories, Inc..
- Product NDC
- 64850-841
- Status
- Listed
- Labeler
- Elite Laboratories, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076686
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64850-841 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DANTROLENE SODIUM50 mg/1
Pharmacologic classes
Decreased Striated Muscle Contraction [PE]; Decreased Striated Muscle Tone [PE]; Skeletal Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64850-841-01 | 64850084101 | 100 CAPSULE in 1 BOTTLE (64850-841-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e637fb20-6a17-4522-810a-990bf1409732NADAC price for package 64850084101
GET /v1/drugs/nadac/64850084101
Use it
Look up 64850-841 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64850-841 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64850-841. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.